These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21965162)

  • 1. Sunitinib-induced nephrotic syndrome in association with drug response in a patient with Xp11.2 translocation renal cell carcinoma.
    Liu YC; Chang PM; Liu CY; Yang CY; Chen MH; Pan CC; Chen MH
    Jpn J Clin Oncol; 2011 Nov; 41(11):1277-81. PubMed ID: 21965162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case study of metastatic Xp11.2 translocation renal cell carcinoma effectively treated with sunitinib.
    Numakura K; Tsuchiya N; Yuasa T; Saito M; Obara T; Tsuruta H; Narita S; Horikawa Y; Satoh S; Habuchi T
    Int J Clin Oncol; 2011 Oct; 16(5):577-80. PubMed ID: 21161315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network.
    Malouf GG; Camparo P; Oudard S; Schleiermacher G; Theodore C; Rustine A; Dutcher J; Billemont B; Rixe O; Bompas E; Guillot A; Boccon-Gibod L; Couturier J; Molinié V; Escudier B
    Ann Oncol; 2010 Sep; 21(9):1834-1838. PubMed ID: 20154303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma.
    Choueiri TK; Lim ZD; Hirsch MS; Tamboli P; Jonasch E; McDermott DF; Dal Cin P; Corn P; Vaishampayan U; Heng DY; Tannir NM
    Cancer; 2010 Nov; 116(22):5219-25. PubMed ID: 20665500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent complete response after single-agent sunitinib treatment in a case of TFE translocation positive relapsed metastatic pediatric renal cell carcinoma.
    Chowdhury T; Prichard-Jones K; Sebire NJ; Bier N; Cherian A; Sullivan MO; O'Meara A; Anderson J
    J Pediatr Hematol Oncol; 2013 Jan; 35(1):e1-3. PubMed ID: 22995920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of adult metastatic Xp11 translocation renal cell carcinoma treated successfully with sunitinib.
    Choueiri TK; Mosquera JM; Hirsch MS
    Clin Genitourin Cancer; 2009 Oct; 7(3):E93-4. PubMed ID: 19815489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An adult Xp11.2 translocation renal carcinoma showing response to treatment with sunitinib.
    Pwint TP; Macaulay V; Roberts IS; Sullivan M; Protheroe A
    Urol Oncol; 2011; 29(6):821-4. PubMed ID: 19962921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma : A Case Report].
    Yoshinaga A; Kamata S
    Hinyokika Kiyo; 2015 May; 61(5):201-5. PubMed ID: 26087822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncommon side effect with a commonly used targeted agent: sunitinib-induced nephrotic syndrome in a patient with metastatic renal cell carcinoma.
    Quintyne KI; Neenan T; Casserly L; Gupta R
    BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24872478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Therapy for Renal Cell Carcinoma.
    Joshi R; Rawal S
    JNMA J Nepal Med Assoc; 2015; 53(198):83-8. PubMed ID: 26994026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal carcinoma with (6;11)(p21;q12) translocation: report of an adult case.
    Ishihara A; Yamashita Y; Takamori H; Kuroda N
    Pathol Int; 2011 Sep; 61(9):539-45. PubMed ID: 21884304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological characteristics of pediatric renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.
    Song HC; Sun N; Zhang WP; He L; Fu L; Huang C
    J Pediatr Surg; 2014 Apr; 49(4):539-42. PubMed ID: 24726108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney carcinoma associated with Xp11.2 translocation / TFE3 (ASPL-TFE3) gene fusion.
    Salles PG; Soto M
    Int Braz J Urol; 2005; 31(3):251-4. PubMed ID: 15992428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The preliminary experiences of translocation renal cell carcinoma and literature review.
    Su HH; Sung MT; Chiang PH; Cheng YT; Chen YT
    Kaohsiung J Med Sci; 2014 Aug; 30(8):402-8. PubMed ID: 25002378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Treatment With Sequential Molecular Targeted Therapy for Xp11.2 Translocation Renal Cell Carcinoma: A Case Report and Review of the Literature.
    Kakoki K; Miyata Y; Mochizuki Y; Iwata T; Obatake M; Abe K; Nagayasu T; Sakai H
    Clin Genitourin Cancer; 2017 Jun; 15(3):e503-e506. PubMed ID: 28190703
    [No Abstract]   [Full Text] [Related]  

  • 16. [PATHOLOGICAL COMPLETE RESPONSE WITH EVEROLIMUS FOR MULTIPLE LUNG METASTASES OF RENAL CELL CARCINOMA RESISTANT TO SUNITINIB].
    Namura K; Otake S; Sawada T; Fujikawa A; Ota J; Moriyama M
    Nihon Hinyokika Gakkai Zasshi; 2015 Jan; 106(1):30-4. PubMed ID: 26399128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal Cell Carcinoma Associated With Xp11.2 Translocation/TFE3 Gene-fusion: A Long Response to mammalian target of rapamycin (mTOR) Inhibitors.
    Rua Fernández OR; Escala Cornejo R; Navarro Martín M; García Muñoz M; Antunez Plaza P; García Dominguez AR; Cruz Hernández JJ
    Urology; 2018 Jul; 117():41-43. PubMed ID: 29702156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.
    Wang Z; Liu N; Gan W; Li X; Zhang G; Li D; Guo H
    J Int Med Res; 2017 Aug; 45(4):1287-1296. PubMed ID: 28587544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudocapsule of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: a clue for tumor enucleation?
    Cheng X; He J; Gan W; Fan X; Yang J; Zhu B; Guo H
    Int J Clin Exp Pathol; 2015; 8(5):5403-10. PubMed ID: 26191243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted therapy in Xp11 translocation renal cell carcinoma.
    Gomolčáková J; Brezinová B; Dubovan P; Jurišová S; Rejlekova K; Chovanec M; Mardiak J; Mego M
    Klin Onkol; 2021; 34(2):137-140. PubMed ID: 33906362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.